{"id":"W1905767239","doi":"10.1111/hdi.12329","title":"Sequential molecularly targeted drug therapy including axitinib for a patient with end‐stage renal failure and metastatic renal cell carcinoma","year":2015,"lang":"en","type":"article","venue":"Hemodialysis International","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Axitinib; Medicine; Sunitinib; Sorafenib; Renal cell carcinoma; Everolimus; Targeted therapy; Hemodialysis; Internal medicine; Adverse effect; Oncology; End stage renal disease; Stage (stratigraphy); Urology; Cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000157963,0.0004071943,0.0007926735,0.0005323843,0.001649527,0.0003954841,0.0004500038,0.001520071,0.001069625],"category_scores_gemma":[0.0004332683,0.0002387811,0.00062086,0.0005914058,0.0003578437,0.0005886825,0.0003320698,0.001742341,0.0002896769],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007076251,"about_ca_system_score_gemma":0.000736524,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001585856,"about_ca_topic_score_gemma":0.004717516,"domain_scores_codex":[0.9999125,0.00001066209,0.00001073486,0.00001881397,0.0000168308,0.00003050415],"domain_scores_gemma":[0.9997891,0.00002757749,0.00002257471,0.000005038699,0.000009690892,0.0001461651],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"case_report","study_design_scores_codex":[0.000871598,0.0006627209,0.02915268,0.0001975683,0.00007094764,0.9365966,0.0003288806,0.0007960553,0.007166487,0.0006597969,0.003644355,0.01985234],"study_design_scores_gemma":[0.000337839,0.002184423,0.03792914,0.00006429251,0.0001425302,0.9419005,0.0002349214,0.003117706,0.003506998,0.0009543378,0.009569202,0.00005816537],"study_design_candidate":"case_report","study_design_consensus":"case_report","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9561162,0.0117037,0.003169965,0.01487475,0.0005050291,0.0002282061,0.0002212056,0.0001589851,0.01302202],"genre_scores_gemma":[0.9912042,0.002833412,0.001270831,0.002463479,0.0004344867,0.00002609676,0.0001456792,0.00001125699,0.001610585],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001649527,"threshold_uncertainty_score":0.005134225,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03988296201278138,"score_gpt":0.2770670589675848,"score_spread":0.2371840969548034,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}